Journal of Clinical Endocrinology & Metabolism, Vol 61, 601-606, Copyright © 1985 by Endocrine Society

ARTICLES

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

F Llach and SG Massry

The effect of prolonged (60 days) dietary phosphate restriction on divalent ion metabolism was studied in four patients with moderate renal insufficiency in an effort to delineate the mechanisms of secondary hyperparathyroidism in renal failure. The patients had low normal serum phosphorous and normal vitamin D metabolite levels but had evidence of disturbances in target organs for vitamin D, including impaired intestinal absorption of calcium, reduced calcemic response to PTH, low serum ionized calcium levels, and, consequently, elevated PTH levels. After dietary phosphate restriction, there was marked improvement or normalization of intestinal absorption of calcium, calcemic response to PTH, and ionized calcium and PTH levels. There was also a significant rise (44%) in serum 1,25-dihydroxyvitamin D levels. The data suggest that intracellular phosphorous retention, which may develop as renal insufficiency ensues, may interfere with the action and production of 1,25-dihydroxyvitamin D. This leads to defective intestinal calcium absorption and reduced calcemic responses to PTH. As a result, hypocalcemia develops, causing secondary hyperparathyroidism. Our data assign a critical role for a disturbance(s) in vitamin D metabolism in genesis of the hyperparathyroidism of renal failure.

This article has been cited by other articles:

				C. P. Kovesdy, R. Mehrotra, and K. Kalantar-Zadeh Battleground: Chronic Kidney Disorders Mineral and Bone Disease Calcium Obsession, Vitamin D, and Binder Confusion Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 168 - 173. [Abstract] [Full Text] [PDF]

				O. Gutierrez, T. Isakova, E. Rhee, A. Shah, J. Holmes, G. Collerone, H. Juppner, and M. Wolf Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2205 - 2215. [Abstract] [Full Text] [PDF]

				M. Rodriguez, E. Nemeth, and D. Martin The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism Am J Physiol Renal Physiol, February 1, 2005; 288(2): F253 - F264. [Abstract] [Full Text] [PDF]

				C.-y. Hsu and G. M. Chertow Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1419 - 1425. [Abstract] [Full Text] [PDF]

				J. Coladonato, P. Klassen, and W. F. Owen Jr Perception versus Reality of the Burden of Chronic Kidney Disease in the United States J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1686 - 1688. [Full Text] [PDF]

				A. CANALEJO, Y. ALMADÉN, V. TORREGROSA, J. C. GOMEZ-VILLAMANDOS, B. RAMOS, J. M. CAMPISTOL, A. J. FELSENFELD, and M. RODRÍGUEZ The In Vitro Effect of Calcitriol on Parathyroid Cell Proliferation and Apoptosis J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1865 - 1872. [Abstract] [Full Text]

				E. Soliman, L. Canaff, J. Fox, and G. N. Hendy In Vivo Regulation of Chromogranin A Messenger Ribonucleic Acid in the Parathyroid by 1,25-Dihydroxyvitamin D: Studies in Normal Rats and in Chronic Renal Insufficiency Endocrinology, June 1, 1997; 138(6): 2596 - 2600. [Abstract] [Full Text] [PDF]

				N. A T Hamdy, J. A Kanis, M. N C Beneton, C. B Brown, J. R Juttmann, J. G M Jordans, S. Josse, A. Meyrier, R. L Lins, and I. T Fairey Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure BMJ, February 11, 1995; 310(6976): 358 - 363. [Abstract] [Full Text]